0000899243-20-004524.txt : 20200213 0000899243-20-004524.hdr.sgml : 20200213 20200213183300 ACCESSION NUMBER: 0000899243-20-004524 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200205 FILED AS OF DATE: 20200213 DATE AS OF CHANGE: 20200213 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: El-Hibri Fuad CENTRAL INDEX KEY: 0001380185 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-33137 FILM NUMBER: 20612729 MAIL ADDRESS: STREET 1: 2273 RESEARCH BLVD, SUITE 400 CITY: ROCKVILLE STATE: MD ZIP: 20850 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Emergent BioSolutions Inc. CENTRAL INDEX KEY: 0001367644 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 141902018 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 400 PROFESSIONAL DR, SUITE 400 CITY: GAITHERSBURG STATE: MD ZIP: 20879 BUSINESS PHONE: 240-631-3200 MAIL ADDRESS: STREET 1: 400 PROFESSIONAL DR, SUITE 400 CITY: GAITHERSBURG STATE: MD ZIP: 20879 4/A 1 doc4a.xml FORM 4/A SUBMISSION X0306 4/A 2020-02-05 2020-02-07 0 0001367644 Emergent BioSolutions Inc. EBS 0001380185 El-Hibri Fuad 400 PROFESSIONAL DRIVE, SUITE 400 GAITHERSBURG MD 20879 1 1 1 0 Chairman Common Stock 2020-02-05 4 M 0 20000 25.62 A 1499018 D Common Stock 2020-02-05 4 M 0 20000 25.62 A 1519018 D Common Stock 2020-02-05 4 M 0 8316 25.62 A 1479018 D Common Stock 2020-02-06 4 M 0 11684 25.62 A 1479018 D Employee Stock Options (Right to Buy) 25.62 2020-02-05 4 M 0 20000 0.00 D 2021-03-10 Common Stock 20000 103318 D Employee Stock Options (Right to Buy) 25.62 2020-02-05 4 M 0 20000 0.00 D 2021-03-10 Common Stock 20000 83318 D Employee Stock Options (Right to Buy) 25.62 2020-02-05 4 M 0 8316 0.00 D 2021-03-10 Common Stock 8316 75002 D Employee Stock Options (Right to Buy) 25.62 2020-02-06 4 M 0 11684 0.00 D 2021-03-10 Common Stock 11684 63318 D All transactions listed on this Form 4 were made by the Reporting Person pursuant to a trading plan adopted on September 4, 2019 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934. The reported option exercises were inadvertently omitted from the original Form 4 filed with the Securities and Exchange Commission ("SEC") on February 7, 2020, which reported the sales of shares of the Issuer's common stock ("Common Stock") only, rather than the exercises of the options and subsequent sales of the shares of Common Stock acquired upon such exercises. The number of shares of Common Stock directly beneficially owned by the Reporting Person reported on this amended Form 4 gives effect to the sale of Common Stock by the Reporting Person as reported on the Form 4 filed by the Reporting Person with the SEC on February 7, 2020. The options vested in three equal installments on March 10 2015, March 10, 2016 and March 10, 2017. /s/ Carl A. Valenstein, attorney-in-fact 2020-02-13